← Back to Search

Standard Care: Telehealth appointments for Type 1 Diabetes (CTC Trial)

N/A

Waitlist Available

Led By Jennifer K Raymond, MD, MCR

Research Sponsored by Children's Hospital Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up hba1c for the last 12 months

Awards & highlights

CTC Trial Summary

This trial is testing a new patient-centered care model delivered by telehealth or in-person to young adults with type 1 diabetes. The care model includes shared decision making, goal setting and action planning, and expert- or peer-led sessions.

Eligible Conditions

Type 1 Diabetes

CTC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ hba1c for the last 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~hba1c for the last 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and hba1c for the last 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with completed appointments in telemedicine cohort

Number of participants with completed medical appointments in standard care cohort

Patient Experience

+5 more

Secondary outcome measures

Cost to Instituition

Cost to Payor

Cost to Payor as as assessed using the Team Costs- YA

+3 more

Other outcome measures

Assessment of Diabetes-Related Psychosocial Self-Efficacy

CoYoT1 Care - Tools Questions

Depressive symptoms assessed using the Center of Epidemiologic Studies Scale (CES-D)

+5 more

CTC Trial Design

4Treatment groups

Experimental Treatment

Group I: Standard Care: Telehealth appointmentsExperimental Treatment1 Intervention

Telehealth - with provider and/or team. See previous detailed description.

Group II: Standard Care: Standard appointmentsExperimental Treatment1 Intervention

Usual in-person medical appointments. See previous detailed description. COVID-19 Update: Current clinic appointments consist of telehealth appointments only. Any additional community and CHLA based educational and support events will be following COVID-19 guidelines.

Group III: CoYoT1 Care: Telehealth appointmentsExperimental Treatment1 Intervention

Telehealth - with provider and/or team. See previous detailed description.

Group IV: CoYoT1 Care: Standard AppointmentExperimental Treatment1 Intervention

In-person - medical appointments with provider and/or team. See previous detailed description. COVID-19 Update: Current clinic appointments consist of telehealth appointments only. Any additional community and CHLA based educational and support events will be following COVID-19 guidelines.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CoYoT1 Care

2019

N/A

~90

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Children's Hospital Los AngelesLead Sponsor

232 Previous Clinical Trials

5,076,442 Total Patients Enrolled

University of Southern CaliforniaOTHER

906 Previous Clinical Trials

1,596,206 Total Patients Enrolled

Rutgers UniversityOTHER

113 Previous Clinical Trials

2,804,011 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What goal is this experiment hoping to fulfill?

"The primary assessment for this trial, which will span 12 months or so, is the total of patients that have completed their appointments via telemedicine. Secondary objectives to be measured include Patient Costs (as determined by a polar/multiple choice survey and open-ended questions), Glycemic Control Progression (which can be gauged with HbA1c % readings from EMRs) and Cost to Payor (determined through an inquiry into training time needed on billing process, data collection process etc.)."

Answered by AI

What criteria must be met in order to participate in this trial?

"To be eligible to join this medical study, participants must possess type II diabetes and an autoimmune disorder while also being aged between 16 and 25. The total number of people needed is 80."

Answered by AI

Are there currently openings for participants in this experiment?

"According to information hosted by clinicaltrials.gov, this research endeavor is no longer looking for new participants as its last update was on April 25th 2022. Nonetheless, there are other 370 studies currently recruiting patients into their trials."

Answered by AI

Are elderly individuals eligible to take part in this scientific experiment?

"In order to be included in this medical trial, participants must fall within the age range of 16-25. Alternatively, there are 155 trials for minors and 177 studies geared toward patients over 65."

Answered by AI

Recent research and studies

DiabetesJournal

Orals

“Orals”. 2013. “Orals”. Diabetes. American Diabetes Association. doi:10.2337/db13-1-387.

Current Diabetes ReviewsJournal

Diabetes in Ethnically Diverse Youth: Disparate Burden and Intervention Approaches

Naranjo, Diana, David Schwartz, and Alan Delamater. 2015. “Diabetes in Ethnically Diverse Youth: Disparate Burden and Intervention Approaches”. Current Diabetes Reviews. Bentham Science Publishers Ltd.. doi:10.2174/1573399811666150421115846.

The Journal of PediatricsJournal

Social Determinants of Health on Glycemic Control in Pediatric Type 1 Diabetes

Zuijdwijk, Caroline S., Meaghan Cuerden, and Farid H. Mahmud. 2013. “Social Determinants of Health on Glycemic Control in Pediatric Type 1 Diabetes”. The Journal of Pediatrics. Elsevier BV. doi:10.1016/j.jpeds.2012.12.010.

Diabetes CareJournal